Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw
Authors:
- J. KatzJKJ. Katz
- Y. GongYGY. Gong
- 1 June 2011
- journal article
- research article
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 40 (6) , 605-611
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Genome-wide association studies in pharmacogenomicsNature Reviews Genetics, 2010
- Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jawThe Lancet Oncology, 2008
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the JawsJournal of Oral and Maxillofacial Surgery, 2007
- Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in menHuman Genetics, 2005
- Polymorphisms in the osteopontin promoter affect its transcriptional activityPhysiological Genomics, 2004
- Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the kneeArchives of orthopaedic and trauma surgery, 2004
- ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantationPharmacogenetics, 2003
- Pathogenesis and natural history of osteonecrosisSeminars in Arthritis and Rheumatism, 2002
- The Mineralization Density of Iliac Crest Bone from Children with Osteogenesis ImperfectaCalcified Tissue International, 1999
- Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 geneNature Genetics, 1996